A Distinct Immunophenotype Identifies a Subset of NPM1 -Mutated AML With TET2 or IDH1/2 Mutations and Improved Outcome

American Journal of Hematology - United States
doi 10.1002/ajh.25018
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

NPM1 Mutant Variant Allele Frequency Correlates With Leukemia Burden but Does Not Provide Prognostic Information in NPM1-mutated AML

American Journal of Hematology
Hematology
2019English

Long Non-Coding RNA Expression Profile in Cytogenetically Normal Acute Myeloid Leukemia Identifies a Distinct Signature and a New Biomarker in NPM1-mutated Patients

Haematologica
Hematology
2017English

A Blastic Plasmacytoid Dendritic Cell Neoplasm-Like Phenotype Identifies a Subgroup of Npm1-Mutated Acute Myeloid Leukemia Patients With Worse Prognosis

American Journal of Hematology
Hematology
2017English

Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate

Nature
Multidisciplinary
2009English

Genomic 5-Hydroxymethylcytosine Levels Correlate With TET2 Mutations and a Distinct Global Gene Expression Pattern in Secondary Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma

Journal of Cancer
Oncology
2018English

Concurrent STAT3, DNMT3A, and TET2 Mutations in T-LGL Leukemia With Molecularly Distinct Clonal Hematopoiesis of Indeterminate Potential

American Journal of Hematology
Hematology
2016English

Acute Myeloid Leukemia With Mutated NPM1 Demonstrating Multilineage Dysplasia and Marked Thrombocytosis

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy